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Adult cardiac stem cells are multipotent and robustly
myogenic: c-kit expression is necessary but not
sufficient for their identification
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Teresa Mancuso1, Pina Marotta1, Walter Sacco1, Fiona C Lewis3, Liam Couch4, Victoria Shone3, Giulia Gritti3, Annalaura Torella5,
Andrew J Smith1,6, Cesare MN Terracciano4, Domenico Britti7, Pierangelo Veltri2, Ciro Indolfi1, Bernardo Nadal-Ginard*,1,9,
Georgina M Ellison-Hughes*,3,9 and Daniele Torella*,1,9
Multipotent adult resident cardiac stem cells (CSCs) were first identified by the expression of c-kit, the stem cell factor receptor.
However, in the adult myocardium c-kit alone cannot distinguish CSCs from other c-kit-expressing (c-kitpos) cells. The adult heart
indeed contains a heterogeneous mixture of c-kitpos cells, mainly composed of mast and endothelial/progenitor cells. This
heterogeneity of cardiac c-kitpos cells has generated confusion and controversy about the existence and role of CSCs in the adult
heart. Here, to unravel CSC identity within the heterogeneous c-kit-expressing cardiac cell population, c-kitpos cardiac cells were
separated through CD45-positive or -negative sorting followed by c-kitpos sorting. The blood/endothelial lineage-committed
(Lineagepos) CD45posc-kitpos cardiac cells were compared to CD45neg(Lineageneg/Linneg) c-kitpos cardiac cells for stemness and
myogenic properties in vitro and in vivo. The majority (~90%) of the resident c-kitpos cardiac cells are blood/endothelial lineage-
committed CD45posCD31posc-kitpos cells. In contrast, the LinnegCD45negc-kitpos cardiac cell cohort, which represents ⩽ 10% of the
total c-kitpos cells, contain all the cardiac cells with the properties of adult multipotent CSCs. These characteristics are absent from
the c-kitneg and the blood/endothelial lineage-committed c-kitpos cardiac cells. Single Linnegc-kitpos cell-derived clones, which
represent only 1–2% of total c-kitpos myocardial cells, when stimulated with TGF-β/Wnt molecules, acquire full transcriptome and
protein expression, sarcomere organisation, spontaneous contraction and electrophysiological properties of differentiated
cardiomyocytes (CMs). Genetically tagged cloned progeny of one Linnegc-kitpos cell when injected into the infarcted myocardium,
results in significant regeneration of new CMs, arterioles and capillaries, derived from the injected cells. The CSC’s myogenic
regenerative capacity is dependent on commitment to the CM lineage through activation of the SMAD2 pathway. Such regeneration
was not apparent when blood/endothelial lineage-committed c-kitpos cardiac cells were injected. Thus, among the cardiac c-kitpos
cell cohort only a very small fraction has the phenotype and the differentiation/regenerative potential characteristics of true
multipotent CSCs.
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Avariety of endogenous resident cardiac stem/progenitor cells
(CSCs) have been isolated from the adult mammalian heart
through their expression of different surface markers or
alternatively through their ability to form cardiospheres (CS)
in vitro.1–8 Originally, the adult CSCs were characterised by
the expression of the stem cell factor receptor kinase c-kit
while being negative for the blood/endothelial cell lineage
markers.1 These c-kit-positive (c-kitpos) CSCs have been
shown to be clonogenic, self-renewing and multipotent in vitro
and in vivo.1,9–14 In addition, transplantation of CSCs into
damaged myocardium and their subsequent ablation demon-
strated that the CSCs are necessary and sufficient for
myocardial regeneration.9
c-kit is expressed by a heterogeneous cell population within
the heart,10,15–18 yet it has often been assumed that the lone
identification of c-kit expression in a cardiac cell equates to the
identification of a CSC.19–24 This broad extrapolation has
produced considerable controversy about ‘c-kitpos cardiac
1Molecular and Cellular Cardiology, Department of Medical and Surgical Sciences, Magna Græcia University, 88100 Catanzaro, Italy; 2Bioinformatics Laboratory,
Department of Medical and Surgical Sciences, Magna Graecia University, 88100 Catanzaro, Italy; 3School of Basic and Medical Biosciences, Faculty of Life Sciences &
Medicine, Kings College London, Guy's campus, London SE1 1UL, UK ; 4Laboratory of Cell Electrophysiology, National Heart and Lung Institute, Imperial College, London
SW7 2AZ, UK; 5TIGEM (Telethon Institute of Genetics and Medicine) and Department of Biochemistry, Biophysics and Molecular Pathology, Second University of Naples,
Naples, Italy; 6School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK and 7Interdepartmental Veterinary Services Centre,
Department of Health Sciences, Magna Græcia University of Catanzaro, 88100 Catanzaro, Italy
*Corresponding author: D Torella or B Nadal-Ginard, Molecular and Cellular Cardiology, Department of Medical and Surgical Sciences, Magna Graecia University,
Catanzaro, 88100, Italy. Tel: +3909613694185
or GM Ellison-Hughes, School of Basic and Medical Biosciences, Faculty of Life Sciences & Medicine, Kings College London, Guy's campus, London SE1 1UL. Tel: +44 207
848 6074; E-mail: dtorella@unicz.it or bernardo.nadalginard@gmail.com or georgina.ellison@kcl.ac.uk
8These authors equally contributed to this work.
9These authors share the senior authorship for this study.
Received 05.4.17; revised 14.6.17; accepted 03.7.17; Edited by R De Maria
Cell Death and Differentiation (2017), 1–16
Ofﬁcial journal of the Cell Death Differentiation Association
www.nature.com/cdd
Phenotypic identity of adult multipotent CSCs
C Vicinanza et al
2
Cell Death and Differentiation
cells’.19–26 Recently, several groups have used the Cre/lox
genetic cell-fate-mapping strategy to track the fate of c-kitpos
cells.22–24 This approach marks a myocardial c-kitpos cell
population, which in vivo mainly/exclusively differentiated into
endothelial or lymphoid lineage cells but minimally generated
new cardiomyocytes (CMs).22–24 Overlooking the heteroge-
neity of c-kit-expressing cardiac cell cohort, these cell-fate-
mapping results were interpreted as evidence that c-kitpos
CSCs have a minimal/negligible cardiomyogenic
potential.19,22–25
Here we show through clonal derivation, the only reliable
method to identify a stem cell,27 that a cell population
comprising ⩽1% of all cardiac c-kitpos cells possess clono-
genic, self-renewing and cardiac multilineage differentiation
potential in vitro and in vivo. Therefore, c-kit expression by
itself is not sufficient to identify, isolate and/or track the fate of
true CSCs.
Results
A small fraction of c-kitpos cardiac cells in the adult heart
possess tissue-specific stem/progenitor characteristics.
c-kitpos cells were isolated and analysed from adult C57BL/6J
mouse or Wistar rat hearts.15 Most cardiac c-kitpos cells in
myocyte-depleted cell preparations co-express blood/
endothelial cell lineage commitment markers (Linpos) such
as CD45 and CD31 (Figure 1a). CD45 and CD31 are
expressed by 85±5% of cardiac c-kitpos cells (which also
includes all the cells expressing CD34) while only ~ 10% are
negative for blood/endothelial lineage markers (Linneg)
(Figure 1a).
Freshly isolated mouse cardiac cells negatively sorted for
CD45 and positively sorted for c-kit are negative for CD45
(0%) and positive for c-kit (495%; Figure 1b). Because of the
overlap in expression of CD45 and CD31 in the CD45negc-
kitpos cells, CD45 depletion removes all, or almost all, the
CD31pos/CD34pos cells from the total c-kitpos cardiac cells
(Figure 1c). CD45negc-kitpos cardiac cells are practically
negative for CD34 (2± 1%) and CD31 (5± 2%), but express
(in different percentages) Sca-1 (60±10%), Abcg2 (45± 9%),
CD105 (53±8%), CD166 (58±11%), PDGFR-α (40± 7%),
Flk-1 (or KDR; 30±8%), ROR2 (38± 4%), CD13 (10± 4%)
and CD90 (46±7%; Figure 1d; Supplementary Figure S2).
Freshly isolated rat CD45negc-kitpos cardiac cells have a
similar profile (Supplementary Figure S1).
CD45negc-kitpos cardiac cells express Tert (47± 4%), Bmi-1
(51± 4%; Supplementary Figure S3), regulatory genes of
stem cell proliferation and self-renewal,28 as well as the
transcription factors that predict cardiac differentiation
potential,29,30 Gata-4 (47±11%) and Nkx2.5 (9± 4%;
Supplementary Figure S3). Quantitative RT-PCR revealed
that freshly isolated mouse CD45negc-kitpos cardiac cells
express all the above markers along with the pluripotency
genes Oct-4, Nanog, Klf-4 and Sox-2, and other genes
implicated in stem cell renewal and cardiac development
(Supplementary Figure S3).
From 1056 single mouse CD45negc-kitpos cells seeded in
96-well plates in 20% O2, clones were detected in only 3 wells
(Supplementary Figure S3). In contrast, when CD45negc-kitpos
cardiac cells were allowed to recover after isolation as a bulk
culture for one cell passage (P1), we detected 2±1% clonal
growth. It is most likely that cell cycle activation among ‘self-
renewing’ cells may explain the clonogenic difference.31 This
conclusion is supported by the low basal proliferative activity
(5±2% BrdU incorporation; Supplementary Figure S3) of the
freshly isolated CD45negc-kitpos cells, compared to the cells
re-plated at P1 (88±7% BrdU incorporation; Supplementary
Figure S3). The P1 cells maintained a profile of membrane
markers similar to the freshly isolated cells (Supplementary
Figure S4). For this reason, we have generally used P1 cells
as baseline. As expected, the cloning efficiency of
CD45negc-kitpos cardiac cells improves significantly when
grown in physiological O2 concentration (3% O2), reaching
7±2% (Figure 1e).
CD45negc-kitpos cardiac cells grown in suspension at 20% O2
formed CS at a rate of 2200±450 per 105 plated cells
(Supplementary Figure S3) and these increased to
4300±1200 per 105 cells in 3% O2 (Figure 1f). CD45
negc-kitpos
cardiac cells grown in differentiation media for endothelial (EC),
smooth muscle (SMC) and CM lineages, respectively, acquired
phenotypic characteristics of these cell types (Figure 1g;
Supplementary Figure S3), but at different frequencies
(Figure 1g).
In contrast, Linposc-kitpos cardiac cells (i.e., CD45pos
CD31posc-kitpos, ~ 90% of total myocardial c-kitpos cells) did
not form spheres or show clonal expansion when grown in 20
Figure 1 Phenotype and tissue-specific stem/progenitor potential of freshly isolated myocyte-depleted c-kitpos cardiac cells. (a) Flow cytometry dot plots (representative of
n= 6) show the percentage of total c-kitpos cells†, c-kitpos/CD45pos and c-kitpos/CD31pos within the myocyte-depleted cardiac cells of adult mouse hearts. Right panel shows that
the majority of c-kitpos cardiac cells (~90%) are either CD45- or CD31-positive, while only a minority (~10%) are CD45- and CD31-negative. (b) Flow cytometry dot plot shows that
after sequential CD45-negative and c-kit-positive sorting, sorted cardiac cells are uniformly CD45-negative and homogenously c-kit-positive. (c) Flow cytometry dot plot shows
that CD45negc-kitpos sorted cardiac cells contain a miniscule fraction of CD31-positive cells. (d) Flow cytometry dot plots (representative of n= 5) for membrane CD markers of
freshly isolated and MACS-sorted CD45negc-kitpos cardiac cells from normal adult mouse hearts (for each FACS analysis a minimum of six digested hearts were pooled together
before MACS sorting). For FACS isotype control antibodies see Supplementary Figure S2. (e–g) Bar graphs show clonogenic capacity (e), and CS formation (f) in myocyte-
depleted cells is confined to CD45neg c-kitpos cardiac cells. c-kitneg cardiac cells and CD45posCD31posc-kitpos cardiac cells did not form clones from single-cell deposition or CSs
from 105 plated cells. Data are mean± S.D., n= 10 (clonogenicity), n= 6 (CS formation). (g) Bar graphs show that cardiac tri-lineage (CM, cTnI; SMC, SMApos; EC, vWFpos)
differentiation capacity in myocyte-depleted cells is confined to CD45neg c-kitpos cardiac cells as evaluated by quantitative immunocytochemistry analysis showing, respectively,
that 34± 6% of them became vWF-positive in basic ECmedia; 29± 5% became SMA-positive in basic SMCmedia; and 18± 3% became cTnI-positive cells in CM differentiation
media. CD45posCD31posc-kitpos almost exclusively differentiate into endothelial vWFpos cells (92± 4%) while negligibly became cTnI-positive (o0.00001%) and only 5± 1%
acquired SMA expression in the relative specific differentiation media. Data are mean± S.D., n= 10. †The yield of total c-kitpos cells after heart dissociation is somewhat variable
depending on the age of the animal, the stock of collagenase and duration of the coronary retro-perfusion step;15 this variability does not affect, or does so minimally, the final
harvest of CSCs
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or 3% O2 (Figures 1e and f), and became vWF-positive in EC
differentiation conditions (Figure 1g). Similarly, c-kitneg cardiac
cells neither cloned/formed CSs (Figures 1e and f).
Linposc-kitpos cardiac cells plated in cardiomyogenic medium,
negligibly became cTnI-positive (Figure 1g) and in SMCmedia
only a small number acquired smooth muscle actin (SMA)
expression (Figure 1g).
Overall, c-kit expression is necessary but not sufficient to
identify and enrich for the small population of cells with CSC
properties. On its own, c-kit expression in the myocardium
mainly identifies the vastly more numerous lineage-committed
mast and endothelial cells and their precursors. CD45-
negative selection followed by c-kit-positive sorting enriches
for cardiac cells that exhibit stem/progenitor characteristics.
This double selection still yields a progenitor cell population
with a heterogeneous phenotype and developmental poten-
tial, comprising a mixture of primitive cells and more
committed progenitors. Thus, true CSC identity can only be
resolved by testing the fate of single cells.
Clonal phenotype of CSCs in vitro. The identification and
phenotypic characterisation of the multipotent and cardiomyo-
genic cohort among the CD45negc-kitpos cells was performed
using single-cell-derived clones from rats for better experimental
suitability.15 CD45negc-kitpos cells were magnetic-activated cell
sorting (MACS)-sorted from myocyte-depleted rat cardiac cells
(Figure 2a). At P1 single cells had 3±1% clonal efficiency in
20% O2, which increased to 8±3% in 3% O2.
Four different CD45negc-kitpos CSC clones (chosen for their
early appearance and fastest growth rate) expressed c-kit
(94±5%), PDGFR-α (88±4%), CD166 (97±2%), SSEA-1
(75±6%), Nestin (75±7%), CD90 (20±8%), ROR2 (5±3%),
CD146 (6±4%), CD13 (5± 3%), Bmi-1 (70±9%), Tert
(88±13%), Gata-4 (83±11%) and Nkx2.5 (70±8%), while
they were (practically) negative for CD45 (0%), CD31 (2±1%)
and CD34 (3±1%) (Figure 2b). These clones also expressed
Oct3/4 (85± 8%), Nanog (80±6%), Klf-4 (77± 8%) and Sox-2
(75±11%; Supplementary Figure S5). A similar multi-marker
expression profile was obtained from typical mouse CSC
clones (Supplementary Figure S6). This multiple membrane
marker profile includesmost, if not all, themarkers, which have
been used to identify all the reported CSC populations.1–8,15
Intriguingly, expression of the mouse-specific CSC marker
Sca-1 is correlated with and dependent on the substrate
culture conditions. Sca-1 significantly decreased when the
clones were grown unattached in Methocult media; Sca-1
expression increased significantly after re-plating these Sca-
1neg/low colonies as adherent cells (Figure 2c). Similar
attachment-dependence was noticed for CD44, CD105 and
CD63 expression (data not shown).
RNA-seq analysis of the global transcriptome of the four rat
CSC clones shows enrichment for genes involved in stem cell
self-renewal, multipotency, cell cycle, RNA processing,
cardiac development and developmental plasticity when
searched through gene ontology (GO) terms by DAVID and
IPA (Figures 2d and e). The global averaged Pearson’s and
Spearman’s correlation coefficients between pairwise com-
parisons were very high (Figure 2f) and corresponds to very
similar transcriptional programme, which is a strong indication
that the four clones are members of a single multipotent
CSC type.
CSC clones have a 20±2 h doubling time and have been
propagated for more than 65 passages and serially
sub-cloned with high efficiency every 10 passages
(Figure 3a). They have maintained a stable phenotype without
signs of growth arrest, senescence or downregulation of
stemness and cardiac gene expression (Figure 3b), and a
normal karyotype without detectable chromosomal alterations
(Supplementary Figure S5). Cloned CSCs generate CSs at
high frequency, which give rise to secondary and tertiary CSs
(Figure 3c). When placed in laminin-coated plastic dishes with
LIF-deprived basic differentiation medium for 14 days the
peripheral cells of the sphere expressed proteins specific of
the CM, EC and SMC lineages (Figure 3d).
CSC cloned cells plated in Methocult media at serial
dilutions to obtain colony-forming units (CFUs), formed
colonies with high efficiency even at a dilution of a single
cell/ml (Figures 3e and f). In contrast, freshly isolated, non-
cloned CD45negc-kitpos cardiac cells, plated at a minimal
density of 50 cells/ml formed colonies at a frequency of 2± 1%
(Figure 3e). Furthermore, density and cell number were
significantly higher in CSC clone-derived colonies than those
from freshly isolated, non-cloned CSCs (Figure 3f). Cloned
CSCs had a higher re-cloning efficiency, CS formation and
multipotent differentiation potential than non-cloned, bulk
culture P1 cells (Figures 3g–i).
These results show that all the cells with CSC character-
istics are confined to the CD45negc-kitpos cell population and
none of the data supports the notion that the adult mammalian
myocardium harbours a population of c-kitneg CSCs. Only
~ 10% of CD45negc-kitpos cardiac cells (which in turn are
~ 10% of the total cardiac c-kitpos population) are clonogenic
and multipotent. Therefore, the cells with a demonstrable
multipotent CSC phenotype represent only 1–2% of the total
myocardial c-kitpos cell population. Given these data, it is
confounding to continue using the redundant name ‘c-kitpos
CSCs’ while ‘CSCs’ is sufficient.
Classic cardiac morphogens instruct CSC’s cardiomyo-
genic commitment. In the embryonic cardiomyogenic spe-
cification process,29,30 ‘cell-autonomous’ decisions operate in
combination with ‘cell-non-autonomous’ events, which depend
on extracellular instructive molecules known as morphogens
or cardiopoietic growth factors (cGFs).32,33 Wnt/β-catenin and
TGF-β/SMAD signalling pathways have well-defined and
distinct functions in mammalian cardiogenesis.34–38 Through
gain- and loss-of-function experiments we investigated their
involvement in growth promotion and cardiomyogenic specifi-
cation of the rat CSCs.
CSCs express the cell-surface receptor of Wnt/β-catenin
canonical pathway, Frizzled, as well as its co-receptor, low-
density lipoprotein receptor-related protein 6 (Supplementary
Figure S7). Wnt-3a, Wnt-3a-conditioned medium and bro-
moindirubin-3′-oxime (BIO) stimulated CSC expansion and
clonogenicity, while canonical Wnt inhibition decreased CSC
proliferation and clonogenicity (Figures 4a and b). These
positive and negative modulators of Wnt/β-catenin acted
through, respectively, stabilising or degrading β-catenin and
its LEF/TCF-dependent transcriptional activity (Figure 4c).
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Figure 2 Phenotype of clonal CD45negc-kitpos CSCs. (a) Flow cytometry dot plot (representative of n= 5) of freshly isolated rat CD45negc-kitpos cardiac cells showing the
enrichment of this cell population after sequential negative – CD45 – and positive – c-kit – cell sorting from the total myocyte-depleted cardiac cells. (b) Flow cytometry dot plots
and confocal images from cytospin preparations (representative of n= 6) showing the CD membrane phenotype and nuclear markers of a typical clone of rat CD45negc-kitpos
CSCs. (c) Flow cytometry histograms (representative of n= 3) show that levels of Sca-1 expression in CD45negc-kitpos clonal CSCs is dependent on cell culture. When grown as
adherent cells on gelatin-coated dishes CD45negc-kitpos clonal CSCs express high levels of Sca-1. When transferred into methylcellulose (MethoCult medium) to avoid adherent
growth, the level of Sca-1 is significantly reduced. When transferred back onto gelatin-coated dishes Sca-1 expression returns to the original levels. (d) Heat map of the most
highly expressed genes (410 mRNA copies) in 4 different rat CD45negc-kitpos CSC clones. The enriched GO terms organised in 10 resulting clusters as analysed by DAVID are
shown. (e) Functional categorisation by Ingenuity Pathway Analysis (IPA) of the top expressed genes by RNA-seq of 4 CD45negc-kitpos CSC clones. Histogram represents the
most significant canonical pathways generated using IPA software. Ratio was calculated by dividing the number of genes from our data set that map to each single pathway by the
total number of genes included into the canonical pathway. (f) Comparisons of global gene expression profiles of 4 different rat CD45negc-kitpos CSC clones. P, Pearson’s
correlation coefficient; S, Spearman’s rank correlation coefficient
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When CSCs were induced to differentiate by LIF withdrawal,
Wnt-3a, Wnt-3a-conditioned medium and BIO significantly
inhibited differentiation with a concomitantly reduced expres-
sion of cardiomyogenic genes (Figure 4d; Supplementary
Figure S7), and reduced number of CSCs differentiating into
myocyte-committed cells (cTnIpos; Figure 4e). In contrast,
Dickkopf-1 (Dkk-1) increased CSC myocyte specification
(Figures 4d–f), even though its effect was not sufficient to
produce a fully differentiated beating phenotype.
CSCs express the cell-surface receptor for TGF-β/SMAD
signalling, TGF-β-R1 (Supplementary Figure S7). Supplemen-
tation with Activin-A specifically induced SMAD2 phosphoryla-
tion in the CSCs (Figure 4g). Conversely, Smad2shRNA reduced
the corresponding mRNA and protein levels (Figure 4g).
Neither BMP-2, BMP-4, TGF-β1 or Activin-A supplementation
nor Smad2 knockdown affected CSC expansion or clonogeni-
city (Figures 4h and i). However, in CM differentiation medium,
BMP-2, BMP-4, TGF-β1 and Activin-A, each significantly
increased the expression of myogenic lineage markers and
the number of cTnIpos myocyte-committed cells (Figures 4j–l).
Concordantly, Smad2shRNA reduced CSC myocyte specifica-
tion and completely blocked the Activin-A-dependent positive
myogenic effect (Figures 4j and l).
These data show that CSCs respond to known cardiac
morphogens as would be expected from true cardiac-specific
stem/progenitor cells. Inhibition of the Wnt canonical pathway
and TGF-β family activation, each independently promotes
cardiomyogenic commitment. Nevertheless, individual
modulation of each of these cGFs is insufficient to generate
fully differentiated contracting CMs.
A stage-specific TGF-β/Wnt family inhibitor cocktail
promotes CSC differentiation into spontaneously con-
tractile myocytes. We tested whether the cGFs32,33,38 and
signalling pathways identified above, when given in a stage-/
sequence-specific manner with or without supplementation
with additional factors, stimulated the production of sponta-
neously contractile CMs from rat cloned CSCs in vitro.
On the basis of the CSC-CS multipotency assay in vitro
(Figure 3d), we developed a CS-beating assay similar to those
used to assess CM differentiation in embryoid bodies15,38
(Supplementary Figure S8). Undifferentiated, clonal CSC-
derived CSs expressed c-kit, Oct-4, Sox-2, Klf-4, Nanog and
Wnt-3a (Supplementary Figure S8). Clonal CSCs were pre-
treated with 100 nM oxytocin for 72 h, left to form CSs for
3–4 days (Supplementary Figure S8) and subsequently plated
on laminin-coated dishes in CM differentiation media deprived
of LIF. Supplementation with different concentrations of
BMP-4 and Activin-A for 4 days increased to ~ 40% the
fraction of cTnIpos myocyte-committed cells (Figure 5a).
Adding Dkk-1 from day 5 onwards (Figure 5a) increased to
~ 60% the cTnIpos cells (Figure 5a). Removing BMP-4 and
Activin-A at day 5 further increased the number of cTnIpos cells
to ~ 70% (Figures 5a and b).
qRT-PCR analysis of the main cardiac transcription factors
and myocyte contractile genes showed that Gata-4, Nkx2.5,
Mef2C and Hand2 are induced in the early time points while
contractile genes – Tnnt2, Myl2, Actc1, Myh7, Pln and Atp2a –
reached their peak of expression at later stages of differentia-
tion (Figure 5c; Supplementary Figure S8). Starting at day 8,
CSC-derived CSs showed robust synchronised beating
(Supplementary Movies 1 and 2). When beating spheres at
day 21 were dissociated to obtain single beating cells
(Supplementary Movie 3), the differentiated CMs had
well-organised sarcomeres with clear cross-striations and
connexin 43 gap junctions (Figure 5d; Supplementary
Figure S8). These data were confirmed by western blots of
protein extracts (Supplementary Figure S8).
Spontaneously contractile CSC-derived CMs (hereafter
iCMs) analysed for standard electrophysiological properties
exhibited robust calcium transients (Figure 5e; Supplementary
Figure S8), and when stimulated at 1 Hz in beating clusters
and up to 2 Hz in monolayer (Supplementary Movie 4), had
typical action potentials (Figure 5f). Upon application of 40 μM
caffeine, a calcium transient (Figure 5g) significantly larger
than control transients (Figure 5h) was observed. This
behaviour is indicative of a functional sarcoplasmic reticulum
in the iCMs.39 Mechanisms of calcium transient decay derived
using established methods40 showed that SERCA and the
sodium calcium exchanger (NCX) contributed approximately
equally to the Ca2+ re-sequestering into the SR (Figure 5i).
These data suggest that both are functionally relevant on a
beat-to-beat basis, similarly to CMs derived from pluripotent
stem cells41 and neonatal CMs (neoCMs).42 Application of
isoprenaline (1 μM) increased the spontaneous beating rate,
whereas carbachol (10 μM), almost abolished automatic
beating (Figure 5j), indicating, respectively, the presence of
robust stimulatory β-adrenergic and inhibitory muscarinic
acetylcholinergic signalling pathways. Finally, CSs generated
from Smad2shRNA CSCs (Supplementary Figure S8) were
significantly impaired in CM commitment (Figure 5a).
These results provide indisputable evidence that CSCs are
cardiomyogenic and respond to and depend on known cardiac
development morphogens to generate contracting cardiac
muscle cells.
CSC-derived CMs show the typical gene expression
profile of postnatal CMs. To determine whether the iCMs
acquire a mature gene expression profile and undergo the
typical transcriptional switch, which accompanies permanent
cell cycle exit during CM terminal differentiation,43–45 we
compared RNA-seq data from CSCs, iCMs, neoCMs and
adult CMs (aCMs; Figures 6a–e; Supplementary Table S1a–e).
Comparison of iCMs with CSCs revealed transcription of
11 530 genes (Figure 6a) with 1737 genes downregulated and
3709 upregulated (both with a fold change (FC) of 2.5) in the
iCMs (Figure 6a; Supplementary Table S1a). The down-
regulated genes are mainly involved in cell division, DNA
replication initiation, DNA repair, cellular response to DNA
damage stimulus, stem cell differentiation, organ regeneration
and cell proliferation (Figure 6b; Supplementary Table S1b).
Conversely, upregulated genes are involved in CM develop-
ment, sarcomere organisation, regulation of myocardial
contraction force, heart development, regulation of heart rate,
and calcium and potassium ion transport (Figure 6b;
Supplementary Table S1b). Genes critical for sarcomere
assembly, which are highly expressed in the adult heart,
showed notably increased expression in the CSC-derived
iCMs (Figure 6e; Supplementary Table S1e). In addition,
genes coding for major inward and outward ion channels,
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Figure 3 Clonogenicity and differentiation potential of clonal CD45negc-kitpos CSCs. (a) Sub-cloning efficiency of a rat c-kitpos CSC clone (Cl) at every tenth passage. Data are
mean±S.D., n= 6. (b) Serial sub-clones of c-kitpos CSCs, generated at P50 of the respective parental clone, maintained similar expression of multipotent and cardiac
transcription factor genes. Colour scale indicates change in Ct (threshold cycle) relative to the normalised GAPDH control. Higher delta Ct values correspond to lower relative
gene expression, with every Ct decrease of 3.3 representing a twofold increase in relative expression. (c) Serial spherogenesis efficiency of a clone of c-kitpos eCSCs (1, primary;
1.1, secondary; 1.1.1, tertiary CSs). Representative image of tertiary CSs are shown in the left panel, bar= 50μm. (d) CSs generated from clonal c-kitpos (green) CSCs plated in
basal differentiation media spontaneously commit to the CM (cTnI, red), smooth muscle (SMA, red) and endothelial (vWF, red) cell lineages. Nuclei are stained in blue by DAPI.
Bar= 50 μm. (e) CFU formation of cloned versus freshly isolated (at passage 1, P1) c-kitpos CSCs plated at different numbers in 1.2 ml of MethoCult medium; *Po0.05 versus
cloned c-kitpos CSCs. Data are mean±S.D., n= 6. (f) Representative light microscopy images of a CFU from freshly isolated (P1) c-kitpos CSCs (left panel) and cloned c-kitpos
CSCs (right panel), bar= 50 μm. (g and h) Clonal-derived c-kitpos CSCs show greater clonogenic (g) and CS formation (h) potential, when compared to freshly isolated (P1)
c-kitpos CSCs. *Po0.05 versus freshly isolated P1. Data are mean± S.D., n= 6. (i) Clonal-derived c-kitpos CSCs show greater differentiation potential into CMs (number of
cTnI-positive cells), SMCs (number of SMA-positive cells) and ECs (number of vWF-positive cells), when compared to freshly isolated c-kitpos CSCs. *Po0.05 versus freshly
isolated P1. Data are mean±S.D., n= 6
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calcium-binding proteins, ion receptors, ion exchangers,
calcium ATPases and calcium-/calmodulin-dependent protein
kinases were upregulated, while cell cycle regulators and
cytokinesis were consistently downregulated in the iCMs
(Figure 6e; Supplementary Table S1e).
Comparison of iCMs with freshly isolated aCMs identified
8365 genes (out of 13 285 detected sequence reads/counts)
expressed in both types, with 2385 genes upregulated and
2535 genes downregulated in iCMs (Figure 6a;
Supplementary Table S1a). Most of the genes with higher
expression in aCMs are involved with sarcomere organisation,
contraction through regulation of potassium and calcium ion
transport, release of sequestered Ca2+ and regulation of heart
rate (Figures 6c and e; Supplementary Table S1c and e).
Contrariwise, almost all of the genes with higher expression in
iCMs are involved in cell division, DNA replication, regulation
of cell cycle and cell proliferation, as well as DNA recombina-
tion and repair (Figures 6c and e; Supplementary Table S1c
and e). Thus, iCMs have not reached complete maturation
compared to aCMs.
As expected from the above, transcriptome comparison of
iCMs with neoCMs showed the highest similarity. Out of
12 507 transcribed genes, 11 262 were equally expressed in
both cell types (Figure 6) while 703 mRNAs were upregulated
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and 542 downregulated in the iCMs (Figure 6a;
Supplementary Table S1a). These upregulated genes are
mostly involved with cell metabolism (fatty acid biosynthetic
and ATP metabolic process) and cell adhesion (negative
regulation of cell–matric adhesion; Figure 6d; Supplementary
Table 1d) while the downregulated genes are related to cell
proliferation and immunity (Figure 6d; Supplementary Table
S1d). More importantly, when RNA-seq data for selected
cardiac muscle and cell cycle genes for each of the four cell
types were clustered, the iCMs’ gene expression profile is
practically indistinguishable from that of neoCMs (Figure 6e;
Supplementary Table S1e).
Overall, CSCs, when properly stimulated in vitro, robustly
commit to and differentiate into well-organised and
functional CMs.
Clonogenic CSCs, but not the total c-kitpos cardiac cells,
are multipotent in vivo and their progeny is necessary for
effective histological and functional myocardial regen-
eration. In apparent discrepancy with these and previous1,9
results, recent publications have reported that the c-kitpos
cardiac cells have minimal/absent cardiomyogenic
potential.22–24,46 However, these reports did not distinguish
among different types of c-kitpos cardiac cells and assumed
that all c-kitpos cells were putative CSCs. Thus, we tested the
regenerative potential of the total cardiac c-kitpos cell
population (constituted by ~99% of non-CSCs) as compared
to true CSCs described here. To genetically mark the total
freshly isolated c-kitpos cardiac cells from adult Wistar rats,
they were transduced with a Lenti-GFP construct
(Supplementary Figure S9). After experimental acute myo-
cardial infarction (AMI) in syngeneic rats, 2x105 GFPposc-
kitpos cells were injected intramyocardial at five sites in the MI
border zone. An identical number of GFP-expressing
clonogenic CD45negc-kitpos CSCs (CSCGFP) were injected
into an additional set of rats.1,9 As placebo control, the same
number of animals were injected with just PBS.
At 28 days post AMI, CSCGFP cells were detected in all
recipient infarcted hearts (Figure 7a), with a significantly
higher engraftment rate in the border/infarct zone, compared
to the distal myocardium (Figure 7b). The CSCGFP cells
produced a robust myocardial regeneration with formation of
new GFPpos CMs, arterioles and capillaries (Figures 7a and
b). As expected for recently born myocytes, most, if not all,
new GFPpos myocytes were mononucleated and of smaller
size than the GFPneg pre-existing, binucleated CMs
(Supplementary Figure S9). The CSCGFP significantly
reduced myocyte apoptosis and hypertrophy, significantly
decreased scar size and LV dilation while they improved
fractional shortening and ejection fraction, compared to saline-
treated controls, which were all in heart failure (Figures 7c and
d; Supplementary Figure S10; Supplementary Table S2).
The hearts injected with total GFPposc-kitpos cardiac cells
showed only rare and scattered GFPpos cell engraftment,
which wasmostly limited to the infarct/border zone (Figures 7a
and b). A minuscule number of GFPpos myocytes (~0.00001%
of total myocardial cell nuclei) was detected and most GFPpos
cells (~90%) co-stained for vWF, confirming their endothelial
lineage and/or phenotype (Figures 7a and b). Most signifi-
cantly, 28 days after AMI, the total c-kitpos cardiac cells had not
shown any protective effect on cardiac dimensions or function
(Figures 7c and d; Supplementary Table S2). Without
exception, each of these animals developed overt heart failure
(Figures 7c and d).
Finally, SMAD2 knocked-down CSCs (CSCGFP-Smad2shRNA)
showed similar engraftment in the border/infarct zone to
CSCGFP (Figure 7e), however, the CSCGFP-Smad2shRNA gen-
erated ~ 10-fold less new myocytes (Figure 7f), which were
significantly smaller than the GFPpos myocytes generated by
the CSCGFP (Figure 7g). The number of GFPpos capillaries
generated by the CSCGFP andCSCGFP-Smad2shRNAwas similar
yet the CSCGFP-Smad2shRNA were significantly less effective in
ameliorating cardiac function than the CSCGFP. Nevertheless,
the cardiac performance of the CSCGFP-Smad2shRNA-treated
animals was slightly better than that of the saline-injected
animals at 28 days post AMI (Figure 7h).
Taken together, the results presented here clearly demon-
strate that only true clonogenic and multipotent CSCs (~1–2%
Figure 4 Canonical Wnt and TGF-β1/SMAD2 pathways govern c-kitpos CSC fate. (a–f) To promote the Wnt/β-catenin pathway we used either soluble Wnt-3a (200 ng/ml),
Wnt-3a-conditioned medium from a Wnt-3a-secreting cell line or BIO (2.5 μM; a specific inhibitor of GSK-3 that stabilises β-catenin). To disrupt the Wnt/β-catenin pathway, clonal
CSCs were treated either with Dkk-1 (150 ng/ml), an inhibitor of canonical Wnts, or transfected with a lentiviral vector carrying a specific shRNA for β-catenin (β-catshRNA). (a and
b) Effect of canonical Wnt pathway activation on c-kitpos CSC proliferation (a) and clonogenicity (b). *Po0.05 versus 0% FBS serum starvation (for 48 h); †Po0.05 versus
relative treatment. Data are mean±S.D., n= 6. (c) Western blot analysis shows that the three different treatments to activate Wnt canonical pathway similarly increase β-catenin
levels when compared to untreated (control, CTRL) CSCs. On the right, immunoprecipitation (IP) and western blot analysis shows increased β-catenin-Tcf nuclear binding in
soluble Wnt3a treated versus untreated c-kitpos CSCs. Finally, western blot on the bottom shows efficient downregulation of β-catenin in c-kitpos CSCs using a lentiviral shRNA
construct. (d) qRT-PCR analysis shows the FC (over c-kitpos CSCs in base differentiation medium) of Oct-4, c-kit, Gata-4, Nkx2.5 and cTnI mRNA transcripts following 14 days in
LIF-deprived differentiation medium in the absence (CTRL) or presence of Wnt3a or Dkk-1. *Po0.05 versus CTRL. †Po0.05 versusWnt-3a-CM. Data are mean± S.D., n= 3.
(e) Canonical Wnt pathway induction or inhibition by Wnt3a, BIO or Dkk-1 inhibits or increases c-kitpos CSC commitment to the CM lineage, respectively. *Po0.05 versus CTRL;
†Po0.05 versus relative treatment. (f) Representative confocal images show CM (red, cTnI) committed cells in CTRL- and Dkk-1-treated c-kitpos CSCs. DAPI stain nuclei in blue.
Bar= 50 μm. (g–l) To evaluate the role of TGF-β/SMAD signalling on CSC activation, BMP-2 (10 ng/ml), BMP-4 (10 ng/ml), TGF-β1 (5 ng/ml) and Activin-A (10 ng/ml) were
added to clonal CSC cultures. Conversely, TGF-β-dependent SMAD2 signalling was disrupted by transfecting a specific shRNA construct in a lentiviral GFP vector (Smad2shRNA).
(g) Activin-A increases SMAD2 phosphorylation in treated versus untreated c-kitpos CSCs. The lentiviral construct carrying a specific shRNA for Smad2 efficiently downregulates
SMAD2 in c-kitpos CSCs. (h and i) Effect of TGF-β family activation on c-kitpos CSC proliferation (h) and clonogenicity (i). *Po0.05 versus all; †Po0.05 versus 0% FBS serum
starvation (for 48 h). Data are mean±S.D., n= 6. (j) TGF-β family activation increases CM commitment of c-kitpos CSCs. *Po0.05 versus CTRL; †Po0.05 versus relative
treatment. Data are mean± S.D., n= 6. (k) Representative confocal image show CM (red, cTnI) committed cells in Activin-A-treated c-kitpos CSCs; DAPI stain nuclei in blue.
Bar= 50 μm. (l) qRT-PCR analysis show the FC (over c-kitpos CSCs in base differentiation medium) of Oct-4, c-kit, Gata-4, Nkx2.5 and cTnI mRNAs following 14 days in LIF-
deprived differentiation medium in the absence (CTRL) or presence of Activin-A or Smad2shRNA+Activin-A. *Po0.05 versus CTRL. †Po0.05 versus Activin-A. Data are
mean±S.D., n= 3
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Figure 5 A stage-specific TGF-β-family/Wnt Inhibitor cocktail induces c-kitpos CSC CSs to differentiate with high efficiency into spontaneously rhythmic beating functional
CMs in vitro. (a) Frequency of cTnI-positive CM-committed cells and percentage of beating cells resulting from the indicated different TGF-β/Wnt cocktail strategies. *Po0.05
versus all. #versus stage 4. Data are mean± S.D., n= 6. (b) Representative confocal image shows cTnI (red) CM-committed cells at 14 days. DAPI stain nuclei in blue.
Bar= 50 μm. (c) qRT-PCR analysis heat map show sequential upregulation of cardiac transcription factors, followed by contractile genes with downregulation of cell cycle
competence genes in differentiating c-kitpos CSC CSs at different time points in the stage-specific TGF-β-family/Wnt inhibitor cocktail. Colour scale indicates change in Ct
(threshold cycle) relative to the normalised GAPDH control. (d) CSC-derived contracting CMs express contractile proteins (Actinin, cTnI, MHC and cardiac Actin) with
co-expression of cardiac transcription factor (Gata-4). The CSC-derived CMs exhibit well-defined sarcomeric structures (z lines and dots) as well as gap junction formation (Cnx-
43) between cells. DAPI stain nuclei in blue. Bar= 20 μm. (e) Representative traces of calcium transients stimulated at 1 Hz, with change in fluo-4 fluorescence normalised to
baseline (F/F0). (f) Representative trace of an action potential stimulated at 1 Hz, with change in di-8-anepps fluorescence normalised to baseline (F/F0). (g) Representative trace
of a caffeine-induced calcium transient, which is preceded by three normal calcium transients stimulated at 1 Hz with change in fluo-4 fluorescence normalised to baseline (F/F0).
(h) Peak fluorescence (F/F0) compared between control calcium transients and caffeine-induced calcium transients indicating a functional sarcoplasmic reticulum (**Po0.01,
n= 6). (i) Rate of calcium transient decay where kTotal= kSERCA+kNCX+kSlow with proportion of calcium extruded by each mechanism represented below (**Po0.01,
***Po0.005, n= 6). (j) Example trace of change in spontaneous beating rate with application of the non-selective β-adrenergic agonist, isoprenaline and the muscarinic
acetylcholine receptor agonist, carbachol
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of the total cardiac c-kitpos cells) have a robust cardiomyogenic
potential and the capacity to functionally regenerate the
infarcted myocardium through the SMAD2 signalling pathway.
In contrast, the vast majority of c-kitpos cardiac cells are not
myogenic, and despite the vasculogenic potential, of most of
them, do not repair the damaged myocardium at the functional
level. Therefore, the vast majority of c-kitpos cardiac cells are
not and should not be considered CSCs.
Discussion
The principal findings of this study are as follows: (i) c-kit
expression on its own cannot identify the small fraction of
multipotent CSCswithin the total c-kitpos cardiac cell cohort; (ii)
a consecutive negative/positive selection for CD45 and c-kit
expression identifies a more restricted (~10% of the total
c-kitpos) but still heterogeneous cardiac cell population, which
contains practically all the resident CSCs. Among these
CD45negc-kitpos cells there is a subpopulation representing
⩽1–2% of the total cardiac c-kitpos cell population that is
clonogenic with consistent self-renewal capacity and multi-
potent cardiac differentiation potential; (iii) CD45negc-kitpos
single-cell-derived clones exhibit a reproducibly similar
genome-wide expression profile, which encompasses all the
different CDmarkers, which have been used to date to identify
CSCs; (iv) clonally derived CSCs show robust self-renewing
and serial sub-cloning capacity, genome stability and multi-
lineage cardiac cell differentiation potential; (v) a sequential
stage-specific combination of canonical Wnt inhibitors and
TGF-β family agonists in vitro stimulates CSC differentiation
into functional and spontaneously contracting cells with a
cellular, electrophysiological and whole transcriptome pheno-
type characteristic of bona fide CMs; and (vi) progeny derived
from a single CD45negc-kitpos clonogenic CSC supports robust
histological and functional myocardial regeneration when
administered post AMI. These results are in stark contrast
with the failure of the total cardiac c-kitpos cell population to
undergo significant myogenesis in vitro or in vivo and to
support any meaningful cellular or functional regeneration
post AMI.
These results should help to provide a plausible and
experimentally grounded interpretation of the conflicting
results recently reported about the nature, identifying markers,
physiological and cardiomyogenic properties of the so-called
c-kitpos cardiac cells. More specifically, the contradictory
results about their role – or lack thereof – in the formation of
new myocytes in adult mammalian myocardium homeostasis
and repair can be easily explained by the very different nature
of the c-kitpos cardiac cell cohort used/marked by different
groups.1,9,15,17–24 Once the fact that true CSCs represent only
1–2% of the cardiac c-kitpos cell population is acknowledged,
the discordance between the results can easily be accounted
Figure 6 c-kitpos CSC-derived CMs (iCMs) possess a genomic expression profile typical of aCMs. RNA-seq data were obtained using mRNA from cloned undifferentiated rat
CSCs, beating colonies of iCMs at 21 days of the CM differentiation in vitro protocol, freshly isolated CMs from hearts of PN 1 to 2-day-old pups and from 12-week-old Wistar rats.
(a) Venn diagram shows distribution of the number of common, downregulated and upregulated genes in the iCMs versus c-kitpos CSCs, iCMs versus aCMs and iCMs versus
neoCMs*. (b) Heat map of RNA-seq profile of the 1737 downregulated and 3709 upregulated genes in the iCMs versus c-kitpos CSCs comparison and their GO clustering for
specific gene function†. (c) Heat map of RNA-seq profile of the 2385 upregulated and 2535 downregulated genes in the iCMs versus aCMs comparison and their GO clustering
for specific gene function†. (d) Heat map of RNA-seq profile of the 703 upregulated and 542 downregulated genes in the iCMs versus neoCMs comparison and their GO clustering
for specific gene function†. (e) Heat map of selected myogenic gene expression (like, Tnnc1, Tnnc2, Tnnt2, Tnnt3, Tnni3, Myh18b, Myh7, Myh6, Mybpc3, Myl2, Myl3 and Actn2)
from RNA-seq analysis in the c-kitpos CSC versus iCM comparison (with accompanying relative expression of the same genes in neoCMs and aCMs) and their GO clustering for
specific gene function§. *Note: specific FCs for each gene in the different comparisons and the gene IDs are reported in Supplementary Table S1a. †Note: each GO clustering for
specific gene function is identified by the right vertical colour band. The GO cluster names and the identification of relative included gene names is reported in Supplementary
Table S1b–d, respectively. §Note: selected myogenic gene names are grouped in different GO clustering for specific gene function that are identified by the right vertical colour
band. The GO cluster names and the identification of relative included gene names is reported in Supplementary Table S1e
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Figure 7 c-kitpos CSCs not c-kitpos cardiac cells are multipotent in vivo. (a) Representative confocal images show GFP-positive cell engraftment and differentiation 28 days
after MI in rats treated with GFP-transduced total c-kitpos cardiac cells or c-kitposCSCs. Most of the GFPpos c-kitpos cardiac cells acquired endothelial lineage specification (vWF,
red, upper mid panel). On the contrary, GFPpos c-kitpos CSCs differentiate into CMs (cTnI, red), arterioles (SMA, red) and capillaries (vWF, red). DAPI stain nuclei in blue.
Bar= 50 μm except for upper right panel= 200 μm and bottom right panel= 25 μm. (b) Bar graphs show cumulative data on total GFP cell engraftment, replenished GFPpos
CMs, arterioles and capillaries in the different groups. *Po0.05 versus total c-kitpos cardiac cells; #Po0.05 versus distant. Data are mean±S.D., n= 5 per group. (c)
Representative M-mode echocardiography images for Sham-operated animals and rats treated with saline, GFPpos total c-kitpos cardiac cells or GFPpos c-kitpos CSCs, 28 days
after MI. (d) Bar graphs show cumulative echocardiographic data for LV end-diastolic diameter (LVEDD), LV end-systolic diameter (LVESD), ejection fraction (EF) and fractional
shortening (FS) in the different groups. *Po0.05 versus Sham; and #Po0.05 versus saline and total c-kitpos cardiac cells. Data are mean±S.D., n= 5 per group. (e–g) GFPpos
c-kitpos CSC engraftment (e), replenished GFPpos CMs (f) and GFPpos CM size (g) 28 days after MI in rats treated with GFPpos c-kitpos CSCs (CSCGFP) or SMAD2shRNA/GFPpos
c-kitpos CSCs (CSCSMAD2shRNA/GFP). *Po0.05 versus CSCGFP. Data are mean±S.D., see Supplementary Table S2 for n values. (h) Echocardiographic data show FS 28 days
after MI in sham-operated animals and in rats treated with Saline, CSCGFP or CSCSMAD2shRNA/GFP. *Po0.05 versus Sham; #Po0.05 versus saline; ^Po0.05 versus CSCGFP.
Data are mean±S.D., see Supplementary Table S2 for n values
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for. The CSCs possess a robust myogenic and regenerative
potential when injected into damaged myocardium (Figure 7;
Supplementary Figures 9 and 10). In contrast, 490% of
cardiac c-kitpos cells are endothelial cells and their precursors
(Figure 1), and their transplantation produced significant neo-
capillarogenesis with no cardiomyogenesis, which did not
improve ventricular function (Figure 7). This result explains
why the genetic c-kit Cre/lox mouse lines mainly track
endothelial cells22–24,47 and when total c-kitpos cardiac cells
are injected post AMI they show no cardiomyogenic
potential.20,46
The results described here indicate that expression of the
stem cell receptor c-kit is an essential marker of the
mammalian CSCs. Indeed, starting with highly heterogeneous
cell populations, all single-cell clones that had the character-
istics of bona fide CSCs were found to be c-kitpos (Figure 1). In
contrast, no clonogenic/self-renewing/mulitpotent cells were
detected in the c-kitneg cohort (Figure 1). Yet, on its own, c-kit
expression in myocardial cells preferentially identifies mast
and endothelial cell lineages. We have shown that combined
use of a small set of positive/negative markers together with
c-kit (Supplementary Figure S11) identifies the complete CSC
cohort with exclusion of other lineage-committed c-kitpos
myocardial cell types. Therefore, we propose that the set of
markers described here be considered a ‘defining phenotype
for the identification and isolation of mammalian adult
endogenous CSCs’, which needs to be taken into account in
the design of any CSC cell-fate-tracking approach.
Materials and Methods
Experimental procedures were carried out under the British Home Office Animal
(Scientific Procedures) Act 1986 or the Italian Ministry of Health Regulation for
experimental animal use and approved by the corresponding Institutional Review
Boards. Animals were housed under controlled conditions of 25 °C, 50% relative
humidity and a 12 h light (0600–1800 hours) and 12 h dark cycle, with water and food
(containing 18.5% protein) available ad libitum.
Rat CM and CSC isolation. CMs and CSCs were isolated from adult male
Wistar rat hearts by enzymatic dissociation.9,15 Hearts were excised, the aorta
cannulated and hung on a retrograde perfusion system. Briefly, this procedure
consists of three main steps: (1) a collagenase type II perfusion of the myocardium
performed at 37 °C with HEPES-MEM, gassed with 85% O2 and 15% N2; (2) the
heart is removed from the apparatus, cut into small pieces and the fragments
shaken in re-suspension medium at 37 °C; and (3) CMs and small cardiac cells are
separated by centrifugation. For isolation of CD45negc-kitpos cells, first the myocyte-
depleted small cardiac cells are incubated with an anti-rat CD45 antibody. After
antibody binding, the CD45pos cells are depleted from the preparation by MACS
(Miltenyi, Cologne, Germany) using anti-Mouse IgG MicroBeads, leaving the
CD45neg fraction. From the CD45neg fraction, the c-kitpos (CD45neg) cardiac cells are
enriched through incubation with a rabbit polyclonal antibody against c-kit, followed
by indirect anti-rabbit IgG microbeads sorting (Miltenyi).9,15
All the specific antibodies are listed in Supplementary Table S3.
Mouse CSC isolation. The same procedure described above9,15 was used to
isolate CSCs from adult mouse hearts but using MACS technology with direct
CD45-negative and then c-kit-positive anti-mouse microbeads sorting (Miltenyi).
All the specific antibodies are listed in Supplementary Table S3.
Cell culture. Freshly isolated CD45neg c-kitpos cardiac cells were plated in
gelatin-coated dishes in CSC growth medium9,15 consisting of Dulbecco’s MEM/
Ham’s F12 (DMEM/F12; Sigma, St. Louis, MO, USA) medium containing 10% ESQ-
FBS (Life Tech, ThermoScientific, Waltham, MA, USA), LIF (10 ng/ml; Miltenyi),
FGF (10 ng/ml; Peprotech, Rocky Hill, NJ, USA), EGF (20 ng/ml; Peprotech),
insulin–transferrin–selenite (Life Tech), EPO (2.5 U; Sigma, only for rat cells), 1%
pen-strep (Life Tech) and 0.1% gentamicin (10 mg/ml liquid, Life Tech). Except
where indicated (low oxygen), cells were maintained at 37 °C in ambient O2 (21%)
and 5% CO2. Media were replenished every 48 h and cells were passaged at a
1:4 ratio.
Clonogenic and spherogenesis assay in vitro. To show clonogenicity,
single-cell cloning was used through depositing single CD45negc-kitpos cardiac cell
or cloned CSC into wells of 96-well gelatin-coated Terasaki plates by serial dilution.
Individual CD45negc-kitpos cells were grown in mCSFM (see below) for 1–3 weeks
when clones were identified and expanded. Mouse CSC clones were expanded on
CELLstart (Life Technologies, Carlsbad, CA, USA) coated plates. The clonogenicity
of the CD45negc-kitpos cells was determined by counting the number of wells in each
96-well plate, which contained clones and expressed as a percentage. Sub-cloning
was performed at every tenth passage and maintenance of clonogenicity and
stemness properties assessed. A total of 10 plates were analysed for each
experiment.
For CS generation, CD45negc-kitpos CSCs were placed in bacteriological dishes
with CS generation medium (mCSFM) composed of 1:1 ratio of CSC growth medium
and Neural Basal Media supplemented with B27 and N2 supplements (Life Tech).
CSs were counted per plate at 14 days and the number expressed as a percentage
relative to the number of plated CSCs.9,15
MethoCult assay in vitro. CFU formation from cloned versus freshly isolated
CSCs was assessed by plating relative cells in 1.2 ml of MethoCult medium
(STEMCELLTechnologies, Vancouver, Canada) (1% methylcellulose in CSC growth
medium). Colonies were counted at 14 days after plating.
BrdU incorporation in vitro and in vivo. To assess the proliferative
activity of CD45negc-kitpos cardiac cells, before harvest in culture, BrdU (50 mg/kg)
was intraperitoneally administered in vivo for 6 days in adult mice every 12 h, before
mouse killing, and then it was administered in the enzymatic solution (10 μM) while
digesting the hearts. After harvest in culture BrdU 10 μM was administered in vitro
every 12 h for 7 days on freshly isolated CD45negc-kitpos cardiac cells and
CD45negc-kitpos cardiac cells at P1. Then cells were analysed by flow cytometry
(PE Anti-BrdU Antibody, Biolegend, San Diego, CA, USA).
Differentiation potential, CS myogenic differentiation and spon-
taneous beating assay in vitro. Freshly isolated or cloned CD45negc-kitpos
CSCs were plated in LIF-deprived basic differentiation medium consisting of
α-MEM, dexamethasone (1 μM), ascorbic acid (50 μg/ml), β-glycerophosphate
(10 mM; all from Sigma) with 3% FBS (Invitrogen, Carlsbad, CA, USA). For specific
myocyte, vascular SMC and EC commitment, TGF-β1 (5 ng/ml, Peprotech), all-
trans retinoic acid (10− 6 mol/l, Sigma) and VEGF-A (10 ng/ml, PeproTech) were,
respectively, added and complete differentiation media refreshed every 72 h. Cell
differentiation was evaluated at 14 days as previously described.9,15,48,49 Briefly,
CM, smooth muscle and endothelial differentiation was quantified by staining for
cTnI, SMA and vWF, respectively. The nuclei were counterstained with 4, 6-
diamidino-2-phenylindole (DAPI). Cells were evaluated using fluorescence and
confocal microscopy. In all, 10 random fields at × 20 magnification were counted for
each dish, and the percentage of cTnI-, SMA- or vWF-positive cells relative to the
total number of cells was calculated. All analysis was performed by investigators
who were blind to the group assignment.
To promote the Wnt/β-catenin pathway, c-kitpos CSCs were treated with soluble
Wnt-3a (150 ng/ml, Peprotech), Wnt-3a-conditioned medium (from a Wnt-3a-
secreting cell line, ATCC, Manassas, VA, USA) or with BIO (2.5 μM; Sigma). To
disrupt Wnt/β-catenin, cells were treated with Dkk-1 (150 ng/ml; R&D System, MN,
USA) or transfected with a lentiviral vector carrying a short hairpin RNA (shRNA) for
rat β-catenin with a GFP reporter (β-catshRNA, Santa Cruz, TX, USA). To evaluate the
role of TGF-β/SMAD signalling, BMP-2 (10 ng/ml; Peprotech), BMP-4 (10 ng/ml;
Peprotech), Activin-A (10 ng/ml; R&D System) and TGF-β1 (5 ng/ml; Peprotech)
were added in the medium. To distrupt TGF-β1-dependent SMAD signalling, c-kitpos
CSC were transfected with lentiviral vector carrying a shRNA specific for rat Smad2
with a GFP reporter (Smad2shRNA, Origene, Rockville, MD, USA). Lentiviral vectors
for β-catenin and Smad2 shRNAs were infected at 100 MOI, and 48 h later, GFP
expression was assessed by live imaging (FLoyd Cell Imaging Station, Life
Technologies, Waltham, MA, USA) and cells were plated for differentiation or sphere
formation as described above. CM differentiation was quantified by staining for cTnI
as above described.
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For CS myogenic differentiation and spontaneous beating assay in vitro, cloned
c-kitpos CSCs plated in flasks were treated with 100 nM oxytocin for 72 h in leukaemia
inhibitory factor-deprived CSC growth medium and then placed in bacteriological
dishes with mCSFM for the generation of CSs for 4 days. Clonogenic c-kitpos CSC-
derived CSs were transferred to laminin (1 μg/ml)-coated dishes in base
differentiation medium (α-MEM), dexamethasone (1 μM), ascorbic acid (50 μg/ml),
β-glycerophosphate (10 mM; all from Sigma) with 2% FBS (Invitrogen). BMP-4
(10 ng/ml; Peprotech) and Activin-A (3, 10 or 30 ng/ml) were added in the medium,
changed after 48 h and removed at 4 days. At day 5, BMP-4 were removed and Dkk-1
(150 ng/ml; R&D System) was added for the remainder of the culture period. At
14 days the number of beating CSs in each dish was calculated on the percentage of
beating CSs relative to the total number of CSs/clusters in each dish.29 Then beating
CSs were either trypsinised for RNA isolation or fixed with 4% PFA and double-
stained for actinin or cTnI and connexin 43 and detected by FITC- and TRICT-
conjugated secondary antibodies (2Abs), respectively. Nuclei were stained with DAPI.
All the specific antibodies are listed in Supplementary Table S3.
Flow cytometry. Cell analysis was performed on FACSCanto II (BD, San Jose,
CA, USA) with FlowJo software (TREE STAR, Inc., OR, USA) to identify the
percentage of cardiac small cells expressing different cell-surface markers of
interest. Specific antibodies used are shown in Supplementary Table S3.
Appropriate labelled isotype controls were used to define the specific gates.
Freshly isolated CD45posc-kitpos cells were sorted on a BD FACSAria III (BD
Biosciences, San Jose, CA, USA).
Immunocytochemistry. Mouse and rat c-kitpos CSCs or c-kitpos CSC-derived
CSs were cultured on glass chamber slides (Thermo Fischer Scientific) for 2 days,
fixed with 4% PFA for 20 min on ice and then stained. For intracellular staining, cells
were permeabilised using 0.1% Triton X-100. Cells were incubated with the primary
antibody overnight at 4 °C, washed three times and then incubated secondary
antibody (Jackson Immunoresearch, West Grove, PA, USA) for 1 h at 37 °C. Then
cells were washed three times and nuclei were counterstained with DAPI (Sigma).
Fluorescence was visualised and images acquired with confocal microscopy (TCS
SP2, Leica, Wetzlar, Germany). Specific primary antibodies are listed in
Supplementary Table S3. All secondary antibodies were purchased from Jackson
Immunoresearch (1:100 dilution).
Cytospin. CD45negc-kitpos cardiac cells were suspended in complete CSC
growth medium. A volume of 200 μl of a 0.3 × 106 cells/ml suspension were directly
loaded in each cytofunnel and spin down at 800 r.p.m. for 3 min onto poly-lysine-
coated slides using a Shandon Cytospin 4 Cytocentrifuge (Thermo Fisher Scientific,
MA, USA). Slides were immediately fixed using a spray fixative (Shandon Cell-Fixx,
Thermo Fisher Scientific) and then processed for immunostaining as above
described. Fluorescence was visualised and images acquired with confocal
microscopy (LEICA TCS SP2).
Quantitative RT-PCR. RNA was extracted from CMs and CSCs using TRIzol
Reagent (Ambion, ThermoFisherScientific, Waltham, MA, USA) and quantitated
using a Nanodrop 2000 Spectrophotometer (Thermo Fisher Scientific). Reverse
transcription was performed with 0.5–1 μg of RNA using the High Capacity cDNA
Kit (Applied Biosystems, Foster City, CA, USA). qRT-PCR was performed using
TaqMan Primer/Probe sets (Supplementary Table S4) using StepOne Plus real
Time PCR System (Applied Biosystems). Data were processed by the ΔCt method
using StepOne Software (Applied Biosystems) v2.3 and mRNA was normalised to
the housekeeping gene, GAPDH. All reactions were carried out in triplicate.
Western blot analysis. Immunoblots and immunoprecipitations were carried
out using protein lysates obtained from CSCs. Generally, aliquots equivalent of
~ 50 μg of protein were separated on gradient (6–15%) SDS-polyacrylamide gels.
After electrophoresis, proteins were transferred onto nitrocellulose filters, blocked
with either 5% dry milk or 5% bovine serum albumin, and incubated with Abs
against c-kit, β-catenin, active β-catenin, Smad2 and phospho-Smad2 at dilutions
suggested by the manufacturers. Actin was used as a loading control. Proteins were
detected by chemiluminescence using horseradish peroxidase-conjugated 2Abs
and the Alliance UVITEC Cambridge system (Eppendorf, Hamburg, Germany).
Electrophysiological functional assessment in vitro
Optical mapping: Cytoplasmic Ca2+ concentration was monitored, loading the
cells with Fluo-4-AM (4 μg/ml, Invitrogen) for 20 min. Cells were perfused at 37 °C
with normal Tyrode solution (140 mM NaCl, 4.5 mM KCl, 10 mM glucose, 10 mM
HEPES, 1 mM MgCl2, 1.8 mM CaCl2; pH 7.4) and field stimulated at 1 Hz (30 V,
10 ms). A 470 nm LED was used to excite the fluorophore, with emission passing
through a 560± 35 nm filter, before being recorded by a NeuroCMOS camera
(0.25 kHz, Redshirt, Cairn Research, Kent, UK).
Membrane potential was monitored by loading di-8-ANEPPs (5 μM, Invitrogen) for
10 min. The excitation-contraction uncoupler, blebbistatin (1 μM, Sigma), was used to
minimise motion artefact. The conditions used above were used, with a 535 nm LED
and 590 nm long-pass filter, recording at 1 kHz.
Calcium and action potential data were analysed using pClamp10 (Axon CNS
Molecular Devices, Sunnyvale, CA, USA).
Caffeine application: Caffeine (40 μM; Sigma) was locally applied to cells using
a glass micropipette, and calcium concentration was measured as above. Three
stimulated transients were recorded before stimulation was turned off and caffeine
applied. Caffeine potently locks open ryanodine receptor, and hence the caffeine-
induced calcium transient is indicative of sarcoplasmic reticulum calcium content.
Rates of calcium transient decay were calculated based on an established
method,1 by fitting a mono-exponential function to the decay in normal calcium
transients and caffeine-induced calcium transients (as presence of caffeine removes
contribution of SERCA) according to the equation: kTotal= kSERCA+kNCX+kSlow.
Pharmacological manipulation of spontaneous beating rate: The
spontaneous beating rate (b.p.m.) of clusters were measured using an IonOptix
Myocyte Contractility System equipped with a Myocam-S camera scanning at
240 Hz (IonOptix Corp., Milton, MA, USA) fixed to a Nikon TE-200 inverted
microscope. Baseline b.p.m. was measured for 10 min once stable, before
application of the non-selective β-adrenergic agonist, isoprenaline (1 μM; Sigma) for
10 min, followed by the muscarinic agonist, carbachol (10 μM; Sigma) for 10 min.
Cells were then washed for reversal of the effect.
RNA-seq
RNA extraction: RNA was extracted from CMs and CSCs using TRIzol Reagent
(Ambion). The extracted RNA integrity was measured with an Agilent 2100
Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA), and a sample with an
RNA integrity number ⩾ 8 was considered acceptable.
Library preparation: The libraries were generated using depleted RNA obtained
from 1 μg total RNA by TruSeq Sample Preparation RNA Kit (Illumina, Inc., San
Diego, CA, USA) according to the manufacturer’s protocol without further
modifications. The first step involves the removal of ribosomal RNA (rRNA) using
biotinylated, target-specific oligos combined with Ribo-Zero rRNA removal beads
that depletes samples of both cytoplasmic and mitochondrial rRNA. Following
purification, the RNA is fragmented into small pieces using divalent cations under
elevated temperature. The cleaved RNA fragments are copied into first strand cDNA
using reverse transcriptase and random primers, followed by second strand cDNA
synthesis using DNA Polymerase I and RNase H. These cDNA fragments then have
the addition of a single ‘A’ base and subsequent ligation of the adapter (multiple
indexing adapters were ligate to the ends of the ds cDNA). The products are purified
and enriched with PCR to create the final cDNA library.
Sequencing: All libraries were sequenced on the Illumina HiSeq 1000 generating
100 bp paired-end reads. The libraries were divided into two groups depending on
how they were prepared.
Bioinformatics analysis: mapping reads to the reference genome: To
perform RNA-seq data analysis, we used Strand NGS tools (http://www.strand-ngs.
com). We set transcriptome and genome with novel splices as alignment and we use
Ensembl (http://www.ensembl.org/index.html) as transcript model. Raw data sequences
(that is, reads) have been pre-processed and then been related to rattus norvegicus
genome (rno5). Parameters have been set as follows: (i) minimum percentage
identity= 90%; (ii) maximum percentage gaps= 5%; (iii) maximum number of novel
splices= 1; and (iv) minimum match length= 25. Reads witho5 valid matches have
been filtered out, finally obtaining expression values for reads (quantification phase). To
detect novel genes and exons we set the parameters, in term of percentile, as follows:
minimum exon length equals to 10.0; minimum intron length equals to 10.0; maximum
intron length equals to 90.0; minimum gene length equals to 10.0; minimum exon
RPKM equals to 50.0, where RPKM, stands for reads per kilo base per million reads,
used to represent read counts over a region of interest.
Differential expressions were performed using DESeq algorithm, available in
StrandNGS (Strand Life Sciences, Bangalore, KA, India). We performed FC analysis
on filtered expression values using normalised signal values that are in log-scale. We
considered a FC cut off equals to 1.5 to identify up- and downregulated genes. For the
experiment on the four rat CSC clones, we filtered on expression values getting
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27 549 of interest genes as results. Similarly, for the comparison of CSCs versus
iCMs versus aCMs data we obtained 27 808 entities. GO (http://www.geneontology.
org/) enrichment analysis has been performed to relate genes to biological
processes, finding significantly enriched GO terms to be compared with the analysed
data set. Heat maps have been created using MeV software (http://www.tm4.org/mev.
html), and a hierarchical clustering has been performed using Pearson’s correlation
as distance metric and average linkage clustering as linkage method identifying
several cluster enriched with DAVID for the functional analysis. DAVID has been used
to select biological and molecular processes, and pathways of interests for the
analysed data set. Statistic values are used to select the more interesting set of genes
in terms of biological processes to annotate and guide clustering analysis.
Finally, ingenuity pathway analysis (http://www.ingenuity.com) has been performed
to identify the main entities related to biological function and diseases. The most
expressed genes have been loading into IPA and functions analysis has been
performed using 0.05 as threshold value. The RNAseq data reported in this paper are
publically available through the GEO accession number GSE95420.
Myocardial infarction. In the in vivo study comparing the cardiac
regenerative potential of total c-kitpos cardiac cells and clonogenic CSCs, male
Wistar rats (280± 10 g) were subjected to MI through permanent ligation of left
descendant anterior coronary artery as previously described.1,9 Thirty minutes later,
2 × 105 c-kitpos GFP-tagged total c-kitpos cardiac cells, 2 × 105 c-kitpos GFP-tagged
CSCs or just saline were transplanted in the border infarct zone.1,9 Additional rats
served as sham-operated controls (Sham). Animals were then killed 28 days later.
For the number of animals for each group see Supplementary Table 2. For the MI
animals, animals were excluded at first echocardiographic assessment if the EF
was ⩾ 70%, indicating limited or no MI had been induced.
Finally, additional rats (n= 3) with LAD ligation treated with GFP-tagged CSCs were
killed 28 days after MI and CMs isolated as described above. Area profile of rod-shaped
CSC-derived GFP+ CMs was evaluated as compared to GFP-negative spared
pre-existing host CMs from same isolated CM preparations. To this aim, fluorescent
microscopic examination was used to capture images of GFPpos and GFPneg
rod-shaped CMs. CM length and width (from which profile area was calculated) were
measured using ImageJ software (National Institutes of Health, Bethesda, MD, USA).
Echocardiography. Echocardiograms were obtained using a Vivid-Q
ultrasound system (GE Healthcare, IL, USA) as previously reported by our
laboratory.9 Animals were anaesthetised with the minimum amount of inhaled
isoflurane needed to prevent movement and placed in the supine position. Hair was
removed from the chest and LV images were obtained using a 12 L-RS transducer
(5.0–13.0 MHz, GE Healthcare) placed parasternally. Parasternal long- and short-
axis views were obtained with both M-mode and two-dimensional echocardiography.
LV dimensions (LV end-diastolic diameter and LV end-systolic diameter) were
measured perpendicular to the long axis of the ventricle at the mid-chordal level on
three consecutive cycles and averaged by two independent observers (IA and EC)
in a blinded manner. Fractional shortening and LV ejection fraction were accordingly
calculated. The numbers of animals for these determinations were as
described above.
Tissue harvesting, histology and immunohistochemistry on LV
cross sections. After completion of the echocardiographic measurements, the
abdominal aorta was cannulated and the heart arrested in diastole using cadmium
chloride (CdCl2). The isolated hearts were perfused with 10% buffered formalin and
cut into right and left ventricles, and right and left atria.9 After being weighed, the LV
was sectioned into three parts, that is, apical, mid and basal regions, embedded in
paraffin and 5 μm cross sections were prepared on a microtome (Leica, Wetzlar,
Germany).
Apoptosis was detected on 5 μm LV sections using the terminal deoxynucleotidyl-
transferase (TdT) assay.9,48 Apoptotic (TdT-positive) myocytes were identified and
quantified (~3000 myocytes were counted per heart and the apoptotic fraction was
expressed as a per cent of total myocyte nuclei) using light, fluorescent (Nikon
E1000M) and confocal microscopy (Zeiss LSM 510, Oberkochen, Germany).
Myocyte diameters was measured across the nucleus on transverse H&E sections
of border infarct zone of the LV (~500 myocytes/animal were sampled).48,49 The
numbers of animals for these determinations were as described above.
Antigen retrieval was achieved using Target Retrieval Solution, Citrate pH 6
(DAKO, Santa Clara, CA, USA). Myocyte cytoplasm was detected using an antibody
against α-sarcomeric actin (1:50 dilution; clone 5C5, Sigma), Myosin heavy chain
(1:50 dilution, clone NOQ7.5.4D, Sigma) or cardiac Troponin I (1:50 dilution; rabbit
polyclonal, Santa Cruz) for 2 h at 37 °C and this was detected with anti-mouse IgM or
IgG anti-rabbit IgG Texas Red (1:100 dilution; Jackson Immunoresearch). GFPpos
cells were detected using a goat polyclonal or rabbit polyclonal antibody against GFP
(1:50 dilution; Rockland Immunochemicals (goat); (Pottsdown, PA, USA) Abcam
(rabbit)) for 1 h at 37 °C and this was detected with an anti-goat or anti-rabbit IgG
FITC (1:100 dilution; Jackson Immunoresearch). GFP-positive CMs, SMCs,
fibroblasts and ECs (capillaries) were identified on LV cross sections by double
staining for GFP and cTnI, or SMA or vWF (1:100 dilution). Secondary Ab incubations
were carried out at 37 °C for 1 h. The nuclei were counterstained with the DNA-
binding dye, DAPI (Sigma) at 1 μg/ml. Sections were mounted in Vectashield and
analysed and scanned using confocal microscopy (Zeiss LSM 710 or Leica
TCS SP5).
For the in vivo regeneration MI assay, total GFPpos cells, GFPpos/cTnIpos,
myocytes, GFPpos/SMApos arterioles and GFPpos/vWFpos capillaries were counted in
the border/infarct and distal areas by counting at × 63 magnification a total of 20 fields
in each area. The counts were pooled for border and infarct, making Border+Infarct.
The number of GFPpos engrafted cells was expressed as a per cent fraction of the
total number of nuclei. The number of GFPpos-cell-derived CMs was expressed as a
per cent fraction of the total myocyte nuclei. Finally, the number of GFPpos-cell-
derived arterioles and capillaries was computed to mm2.
Statistical analysis. Statistical analysis was performed with GraphPad Prism
version 6.00 for Macintosh (GraphPad Software, La Jolla, CA, USA). Quantitative
data are reported as mean±S.E. and binary data by counts. Significance between
two groups was determined by Student’s t-test or paired t-test as appropriate. For
comparison between multiple groups, ANOVA was used. A P-value o0.05 was
considered significant. Bonferroni post hoc method was used to locate the
differences. In these cases, the type 1 error (α= 0.05) was corrected by the number
of statistical comparisons performed.
For the in vitro cell and molecular biology experiments with an n= 4 sample size,
giving the low number of the sample, the Kruskal–Wallis test (for multiple‐group
comparison) and the Mann–Whitney U-test (for comparison between two groups)
were performed.
Biological replicates have been defined as parallel measurements of biologically
distinct samples. Technical replicates are repeated measurements of the same
analysed sample that represent independent measures of the random noise
associated with protocols or equipment. All the N values in the manuscript are
biological replicates unless specifically stated.
The N per group and exact P-values for each experiment are reported in each
figure or table legends.
Power calculations were performed to estimate animal numbers for the MI and cell
injection experiment. On the basis of preliminary results from CSCs injected into MI
rat hearts where EF was measured, with Po0.05; a statistical power of 0.8; a
difference of 8% between 1 day after MI and 28 days after MI+CSCs; and a S.D. of 4,
the estimated sample size generated from a Minitab software (State College, PA,
USA) effect size curve is 6. To allow for an expected mortality of ~ 25% following MI,
we used at least 10 animals/group.
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